| dc.contributor.author | Kirui, Wesley | |
| dc.date.accessioned | 2019-01-14T09:08:32Z | |
| dc.date.available | 2019-01-14T09:08:32Z | |
| dc.date.issued | 2017-04 | |
| dc.identifier.citation | Journal of Chemical, Biological and Physical Sciences, Vol. 7, No. 2; 317-326 | en_US |
| dc.identifier.issn | 2249 –1929 | |
| dc.identifier.uri | http://www.jcbsc.org/test/admin/get_filephy.php?id=520 | |
| dc.identifier.uri | http://repository.seku.ac.ke/handle/123456789/4311 | |
| dc.description.abstract | In this paper, we consider a discrete mathematical model of HIV-1 in vivo dynamics in the presences of chemotherapy and delay in infectivity of target cells. A novel feature in this work is that both delay in infectivity of CD4+T-cells and chemotherapy are incorporated into the discrete HIV-1 in vivo dynamics. We establish the necessary and sufficient condition for global stability of Disease free equilibrium. We also perform numerical simulations which supports the obtained theoretical results. | en_US |
| dc.language.iso | en | en_US |
| dc.subject | Stability | en_US |
| dc.subject | Disease free equilibrium | en_US |
| dc.subject | Delay | en_US |
| dc.subject | Drug Efficacy | en_US |
| dc.title | A discrete model for HIV-1 in vivo dynamics in the presences of chemotherapy with delay in infectivity of target cells | en_US |
| dc.type | Article | en_US |